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The comet assay has developed over the
past 30 years and today, a variety of dif-
ferent DNA lesions and DNA repair can
be measured by different versions of the
assay (Collins, 2004). In the final step of
the method, an image resembling a comet
with a head (the nuclear core) and a tail
(consisting of mainly single stranded DNA
that has migrated out from the cell nuclei)
is analyzed. The magnitude of the comet’s
DNA-tail provides information about the
level of DNA lesions in the cell. The results
from comet assay analyses are reported
using different descriptors, the most fre-
quently used being percentage of DNA in
the tail (%T), tail length and tail moment
(the product of %T and tail length). These
descriptors can be reported in different
ways, i.e., as means, medians or as dis-
tribution patterns. To compile the infor-
mation on the migration of thousands of
comets into a single value that is mean-
ingful to convey to other researchers, is
difficult. The solution has been practi-
cal and controlled by those researchers
with the longest experience with the comet
assay. In this opinion paper, we revisit the
search for a commonly accepted descrip-
tor for DNA damage measured by the
comet assay. We define the “best” comet
assay descriptor as a measurement that
best describes the migration of DNA in
each comet in the agarose, fits the dis-
tribution of comets in the gel, and con-
veys the technical measurement of comets
as a descriptor that other researchers can
understand. It should be emphasized that
we do not embark on amission to promote
only one comet assay descriptor.
WHAT IS THE BEST DESCRIPTOR OF
THE DNA MIGRATION IN THE
AGAROSE GEL?
Figure 1 outlines the number of comet
assay publications and certain events in
the development of comet quantification.
The analysis of the comets (the final
step of the assay) has progressed from
the initial measurements of DNA migra-
tion (length) with an eyepiece micrometer,
through semi-automatic image analysis of
digitized comet images by software pro-
grams, to fully automatic systems with
integrated tracking and image analysis of
comets (Azqueta et al., 2013; Jackson et al.,
2013). This equipment offers new possibil-
ities to analyse comets in ways that were
not previously possible. In addition, the
fully (or semi-) automatic image analysis
systems probably lift some of the restraints
in the assay that are related to the manual
measurement of each comet in the gels.
The majority of publications describing
comet assay results adhere to the assump-
tion that reliable information on the DNA
migration in comets can be obtained by
measuring %T. At an early stage, it was
suggested that the tail moment gave a
better description of the DNA migration
than the more simple measurement of
tail length or %T (Olive et al., 1990). An
objection against tail moment has been
that it is difficult to visualize the comets
based on this descriptor. More refined
ways of describing the DNA migration in
the comets (e.g., “tail inertia” or “tail pro-
file”) have not caught on Hellman et al.
(1995); Bowden et al. (2003). This might
have been due to the debate about tail
moment or to the fact that these descrip-
tors were not part of the software package
for comet analysis at that time.
An alternative to the image analysis sys-
tems is the visual scoring system. This
is based on a simple classification of the
comets into (most commonly) five differ-
ent classes, depending on the appearance
of the comet (Gedik et al., 1992). This way
to classify comets has been shown to be
reproducible between laboratories scoring
the same set of slides (Garcia et al., 2004).
Although it is perceived as being less quan-
titative than computer-based image anal-
ysis systems, there are to the best of our
knowledge no studies that have actually
compared image analysis to visual scor-
ing system in a systematic manner across
laboratories.
WHAT IS THE BEST DESCRIPTION OF
THE DISTRIBUTION OF COMETS IN A
SAMPLE?
Most laboratories measure the DNA
migration by software systems in 50 or
more randomly selected comets per gel in
a minimum of 2 gels (Tice et al., 2000).
This consensus is based on both practi-
cal and statistical considerations. For the
visual classification system it has been
common practice to score 100 comets
per gel, which is probably because it is a
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FIGURE 1 | Number of publications in PubMed using “comet assay” or “microgel
electrophoresis” as search term and introduction of comet descriptors (see text for
references).
relatively fast way of measuring the DNA
migration and therefore one can afford the
luxury of scoring more comets. However,
it has been shown that increasing the
number of scored comets per sample is
associated with lower inter-sample varia-
tion and thereby with increased statistical
power (Forchhammer et al., 2008; Sharma
et al., 2012). These analyzed comets are not
independent since they originate from the
same sample (derived from a single exper-
iment or measurement point). It is there-
fore common practice to regard the mean
or median score of the comets originat-
ing from one sample as a single value. The
damage (i.e., DNA migration) levels in the
analyzed comets are mostly not normally
distributed. Therefore, some researchers
prefer to report the data as median rather
than the mean. In our experience it makes
little difference in the statistical analyses
whether the underlying distribution of the
comets has been described by the median
or mean. In fact, it can be argued that
both the median and mean are rather sim-
ple ways of describing the distribution. It
has been shown that the underlying dis-
tribution of the comets can be described
by a χ2-distribution (Bauer et al., 1998).
The shape of the distribution is described
as number of degrees of freedom and it is
useful for the description of results that
are subject to random variation. This is
meaningful for the analysis of comet assay
descriptors since there are heterogeneities
within the gel, where comets with pre-
sumably the same level of DNA damage
look different at certain positions of the
gel. Nevertheless, this way of describing
the underlying distribution of the comets
has not been explored in detail, despite
the fact that it provides a better fit of
the data than the normal distribution. It
has also been described that the underly-
ing distribution can be fitted to a Weibull
distribution, determined by two different
descriptors, i.e., shape and scale (Ejchart
and Sadlej-Sosnowska, 2003). This distri-
bution has not been used in regular comet
assay analyses, which is probably explained
by the complexity of having to describe the
level of DNA migration by two different
values.
An often-raised question is whether
the comet assay results can be analyzed
by parametric tests when the underlying
distribution is not normally distributed.
Here it is important to keep in mind that
statistical analysis is based on a descrip-
tor for each sample (with its underlying
distribution, e.g., the %T). The distribu-
tion of this descriptor score expressed as
%T in e.g., peripheral blood mononu-
clear cells (PBMCs) from a group of
humans, might be normally distributed
or the data can be transformed to fol-
low a normal distribution by for example
log-transformation.
WHAT IS THE BEST COMET ASSAY
RESULT TO REPORT TO OTHER
RESEARCHERS?
There has been substantial debate over the
years about which primary comet assay
descriptor is the most relevant to use.
Tail length has been discarded by many
researchers since themaximal DNAmigra-
tion is typically reached at low doses of
exposure to DNA strand breaking agents
(at least when analyzed with commonly
used comet assay protocols). The debate
about the use of %T or tail moment has
diverted attention from the real issue of
whether any of these descriptors are mean-
ingful to researchers who are not familiar
with the comet assay. These descriptors are
quite seriously dependent on assay con-
ditions (Azqueta et al., 2011; Ersson and
Möller, 2011), and it would be more rel-
evant to report DNA damage values after
adjustment for the assay-specific condi-
tions, typically by reference to standard
curves. Nevertheless, reference values for
DNA damage in terms of %T in PBMCs
have been useful in human biomonitor-
ing studies, which could be explained by
the fact that most comet assay researchers
in this specific field use similar assay
conditions (Møller, 2006).
WHAT ABOUT THE USE OF A
REFERENCE STANDARD?
As yet there is not a true standard in the
comet assay like those that are used in
chemical analyses. The use of reference
standards has not yet been fully imple-
mented, but it is recommended in pub-
lished guidelines to use both positive and
negative controls. There is no consen-
sus about which agents should be used
and an appropriate choice depends on the
types of DNA-lesions that are measured.
For instance, the detection of oxidatively
damaged DNA requires a specific positive
control for this endpoint. An advantage
of ionizing radiation as positive control is
that it can be applied both as positive con-
trol and calibration curve standard, since it
is well-established how many DNA breaks
a certain dose of ionizing radiation causes.
The drawback is that it requires special
equipment for the exposure.
The European Standards Committee
on Oxidative DNA Damage (ESCODD)
performed the first inter-laboratory trial
to attempt a standardization of comet
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assay on human PBMCs. This project
focused on oxidatively damaged DNA that
can be measured by the comet assay
as formamidopyrimidine DNA glycosylase
(FPG)-sensitive sites. It was shown that
the standardized results (lesions/106 dG
of FPG sensitive sites) were similar to
results obtained with other techniques
(i.e., the alkaline unwinding and alkaline
elution assays) (ESCODD et al., 2005). The
European Comet Assay Validation Group
(ECVAG) subsequently looked further
into approaches to reduce inter-laboratory
variation in DNA damage by the use of
calibration samples for standardization of
comet assay descriptors (Møller et al.,
2010). ECVAG settled on describing the
DNA damage as lesions/106 bp rather than
lesions/106 dG because the comet assay
can be modified to measure various types
of nucleobase lesions.
The first ECVAG trial assessed varia-
tion in the level of DNA strand breaks in
coded cryopreserved calibration standards
and test samples that had been distributed
to 12 laboratories. This showed that all
laboratories detected a dose-response rela-
tionship in coded samples, although there
were differences in the reported values.
The inter-laboratory coefficient of vari-
ation was 47% when the levels of DNA
strand breaks were measured as %T or
comet score, whereas it was 28% after
transformation to lesions/106 bp via the
calibration curve (Forchhammer et al.,
2010). The same analysis for FPG-sensitive
sites showed that the participating lab-
oratories could detect a dose-response
relationship in coded cell samples. The
conversion of %T to lesions/106 bp
increased the percentage of total varia-
tion explained by the inter-sample/subject
variation from 49 to 73% (Johansson et al.,
2010). A subsequent ECVAG trial looked
into a standard comet assay protocol, but
was only partly successful because some
laboratories observed no difference in
calibration curve samples and obtained
negative values of FPG sensitive sites
in human PBMCs (Forchhammer et al.,
2012). ECVAG also showed that the over-
all variation of FPG-sensitive sites in the
PBMCs could be partitioned into inter-
laboratory (56.7%), residual (42.9%),
intra-laboratory (0.2%) and inter-subject
(0.3%) variation (Ersson et al., 2013). The
most important finding in this trial was
that the variation within each laboratory
was relatively low.
Variation in DNA damage can be
diminished by standardization of the pri-
mary comet assay descriptor using calibra-
tion samples. As highlighted by ComNet—
a network of researchers using the comet
assay in human biomonitoring studies—
one of the challenges is to determine
experimental factors that influence relia-
bility and robustness of the comet assay as
a biomonitoring tool (Collins et al., 2014).
For, these kinds of studies, it is important
to have low assay variability among lab-
oratories. The number of scored comets
could be an important determinant in
this respect. But, maybe we also have to
look more ahead and think of develop-
ing comet assay equipment with integrated
calibration samples for standardization,
and/or completely other scoring princi-
ples. Still some work to be done in the next
30 years!
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